Pronunciation: sye-loe-SYE-bin
Mechanism of action: Psilocybin ballicule
What it isProdrug of psilocin, a 5-HT2A agonist; investigational for depression.
Why this oneA supervised session produces effects lasting weeks to months, unlike daily antidepressants.
What limits itAnxiety and blood pressure rise during the session, requiring monitoring. Not approved; contraindicated in psychosis risk.
Pearls
- Suicidality and self-harm reported after dosing; arrange follow-up.
- Lithium co-use linked to seizures.
Molecular structure: Psilocybin
Used for
- treatment-resistant depression (phase 3; FDA breakthrough designation)
Principal riskAnxiety and blood pressure rise during the session, requiring monitoring
Classes and tags
Clinical profile
Therapeutic safety burden3 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Active metabolites
Open Psilocybin in the interactive console ↗
Self-check
- Psilocybin: Which active compound is formed from it?
Psilocin. - Psilocybin: Which psychiatric risk contraindicates it in this source?
Psychosis risk.